These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 22653289

  • 1. Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes.
    Altun B, Yilmaz R, Aki T, Akoglu H, Zeybek D, Piskinpasa S, Uckan D, Purali N, Korkusuz P, Turgan C.
    Am J Nephrol; 2012; 35(6):531-9. PubMed ID: 22653289
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
    Zhuo W, Liao L, Fu Y, Xu T, Wu W, Yang S, Tan J.
    Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure.
    Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, Kirsch T, de Groot K, Laudeley R, Niemczyk E, Güler F, Menne J, Haller H, Fliser D.
    Circulation; 2004 Aug 24; 110(8):1006-12. PubMed ID: 15302785
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
    Peng X, Xu H, Zhou Y, Wang B, Yan Y, Zhang X, Wang M, Gao S, Zhu W, Xu W, Qian H.
    Exp Biol Med (Maywood); 2013 Aug 01; 238(8):960-70. PubMed ID: 23970411
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury.
    Cai J, Yu X, Zhang B, Zhang H, Fang Y, Liu S, Liu T, Ding X.
    Am J Nephrol; 2014 Aug 01; 39(6):466-75. PubMed ID: 24854145
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model.
    Zhang JB, Wang XQ, Lu GL, Huang HS, Xu SY.
    Clin Exp Pharmacol Physiol; 2017 Dec 01; 44(12):1232-1240. PubMed ID: 28688148
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age-dependent responses to renal ischemia-reperfusion injury.
    Kusaka J, Koga H, Hagiwara S, Hasegawa A, Kudo K, Noguchi T.
    J Surg Res; 2012 Jan 01; 172(1):153-8. PubMed ID: 20888591
    [Abstract] [Full Text] [Related]

  • 19. Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via downregulating the signaling of oxidative stress and inflammation in ischemia-reperfusion rats.
    Lee PY, Chien Y, Chiou GY, Lin CH, Chiou CH, Tarng DC.
    Cell Transplant; 2012 Jan 01; 21(12):2569-85. PubMed ID: 22507855
    [Abstract] [Full Text] [Related]

  • 20. Hyperbaric oxygen therapy attenuates renal ischemia/reperfusion injury in rats.
    Solmazgul E, Uzun G, Cermik H, Atasoyu EM, Aydinoz S, Yildiz S.
    Urol Int; 2007 Jan 01; 78(1):82-5. PubMed ID: 17192739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.